Article
Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology - 1 Apr 2011
Wang Chun-Yan, Zheng Wei, Wang Tao, Xie Jing-Wei, Wang Si-Ling, Zhao Bao-Lu, Teng Wei-Ping, Wang Zhan-You
Abstract excerpt
Huperzine A (HupA) is a reversible and selective inhibitor of acetylcholinesterase (AChE), and it has multiple targets when used for Alzheimer's disease (AD) therapy. In this study, we searched for new mechanisms by which HupA could activate Wnt signaling and reduce amyloidosis in AD brain. A nasal gel containing HupA was prepared. No obvious toxicity of intranasal administration of HupA was found in mice. HupA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
